Algert Global LLC raised its position in shares of CorVel Co. (NASDAQ:CRVL – Free Report) by 5.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,455 shares of the business services provider’s stock after acquiring an additional 1,765 shares during the quarter. Algert Global LLC owned about 0.19% of CorVel worth $8,252,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of CRVL. Norges Bank bought a new stake in CorVel during the fourth quarter valued at $19,974,000. Corient Private Wealth LLC boosted its position in shares of CorVel by 30.0% during the 4th quarter. Corient Private Wealth LLC now owns 2,321 shares of the business services provider’s stock worth $574,000 after purchasing an additional 535 shares in the last quarter. Stifel Financial Corp boosted its position in shares of CorVel by 11.2% during the 4th quarter. Stifel Financial Corp now owns 26,661 shares of the business services provider’s stock worth $6,591,000 after purchasing an additional 2,679 shares in the last quarter. Campbell & CO Investment Adviser LLC boosted its position in shares of CorVel by 76.6% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 3,186 shares of the business services provider’s stock worth $788,000 after purchasing an additional 1,382 shares in the last quarter. Finally, 1832 Asset Management L.P. boosted its position in shares of CorVel by 112.9% during the 4th quarter. 1832 Asset Management L.P. now owns 1,703 shares of the business services provider’s stock worth $421,000 after purchasing an additional 903 shares in the last quarter. Institutional investors own 51.36% of the company’s stock.
CorVel Price Performance
CRVL stock opened at $320.37 on Friday. The stock has a market capitalization of $5.50 billion, a PE ratio of 72.81 and a beta of 1.08. The company’s 50-day moving average is $309.31 and its 200-day moving average is $271.55. CorVel Co. has a 1 year low of $187.92 and a 1 year high of $329.23.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a research report on Saturday, August 31st.
Check Out Our Latest Report on CRVL
Insider Buying and Selling
In related news, Director R Judd Jessup sold 2,500 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $311.60, for a total value of $779,000.00. Following the sale, the director now owns 40,777 shares in the company, valued at approximately $12,706,113.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, major shareholder Corstar Holdings Inc sold 23,429 shares of the company’s stock in a transaction dated Friday, July 12th. The shares were sold at an average price of $264.90, for a total value of $6,206,342.10. Following the sale, the insider now owns 6,309,958 shares in the company, valued at approximately $1,671,507,874.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director R Judd Jessup sold 2,500 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $311.60, for a total transaction of $779,000.00. Following the completion of the sale, the director now owns 40,777 shares in the company, valued at approximately $12,706,113.20. The disclosure for this sale can be found here. Insiders have sold 72,431 shares of company stock worth $19,961,847 in the last quarter. Insiders own 47.57% of the company’s stock.
CorVel Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- What is MarketRank™? How to Use it
- CarMax’s Impressive Rally: What Investors Should Watch Next
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 9/23 – 9/27
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Co. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.